Reported resultsCompany-reported
What was reported
Mountain View, Calif. – August 11, 2026 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the second quarter ended June 30, 2026, and provided a corporate update.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 11, 2026 · Open the source ↗
What the evidence supports
NeuroPace published its results for the period in a press release furnished to the SEC (Form 8-K, Item 2.02).
What remains unknown
Audit status of the figures (results furnished on Form 8-K or 6-K are typically unaudited), and anything about future periods. Any outlook is the company's own projection. Figures and claims are the company's own description and have not been independently verified.
Figures as stated
Numbers exactly as written in the source. We don’t annualise, convert or add them up.
| Figure | In context |
|---|---|
| $22.8 million | “•Total revenue of $22.8 million in the second quarter of 2026” Mentions: revenue |
| $22.5 million | “•RNS System revenue of $22.5 million in the quarter, representing 21.3% growth compared to the second quarter of 2025” Mentions: revenue |
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Press release headlineNeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue GuidanceU.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 11, 2026 · Open the source ↗
Press release lead paragraphMountain View, Calif. – August 11, 2026 – NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today reported financial results for the second quarter ended June 30, 2026, and provided a corporate update.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 11, 2026 · Open the source ↗
Amount stated in press release•Total revenue of $22.8 million in the second quarter of 2026U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 11, 2026 · Open the source ↗
Amount stated in press release•RNS System revenue of $22.5 million in the quarter, representing 21.3% growth compared to the second quarter of 2025U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 8-K · Aug 11, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:53 UTC
NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.